Login / Signup

Construction and evaluation of curcumin upconversion nanocarriers decorated with MnO 2 for tumor photodynamic therapy.

Xinru ChenQuandong LiZipeng HuangWen LinYan Ma
Published in: Drug delivery and translational research (2022)
The limited tissue penetration depth and tumor hypoxic microenvironment have become the two pivotal obstacles that alleviate the antineoplastic efficacy in tumor photodynamic therapy (PDT). In the research, MnO 2 -decorated upconversion nanoparticles (UCSMn) have been designed to generate certain oxygen within the solid tumor, and also increase the light penetrating depth due to the optical conversion ability derived from upconversion nanoparticles. Furthermore, upconversion nanoparticles as the inner core are coated by mesoporous silica for the loading of curcumin as photosensitizer and chemotherapeutics, and then a MnO 2 shell is proceeding to grow via redox method. When reaching the tumor tissue, the MnO 2 nanoshells of UCSMn could be rapidly degraded into manganese ions (Mn 2+ ) owing to the reaction with H 2 O 2 in acidic tumor microenvironment, meanwhile producing oxygen and facilitating curcumin release. Once the tumor is illuminated by 980 nm light, the upconversion nanoparticles can transform the infrared light to visible light of 450 nm and 475.5 nm, which can be efficiently absorbed by curcumin, and then produce singlet oxygen to induce tumor cell apoptosis. Curcumin played a dual role which can not only be acted as a photosensitizer, but also a chemotherapeutic agent to further reinforce the antitumor activity. In short, the intelligent nanostructure has the potential to overcome the above-mentioned shortcomings existed in PDT and eventually do work well in the hypoxia tumors. MnO 2 -decorated upconversion nanoparticle to solve the tissue penetration and tumor hypoxic microenvironment for tumor photodynamic therapy.
Keyphrases
  • photodynamic therapy
  • fluorescence imaging
  • cell proliferation
  • risk assessment
  • quantum dots
  • optical coherence tomography
  • human health
  • reduced graphene oxide